Outlook Therapeutics
Alison Oliver is a seasoned professional with extensive experience in project management and brand management within the pharmaceutical and healthcare sectors. Currently serving as Operations Project Manager at Decisive Consulting Ltd, Alison previously held the position of Project Manager at the same company. Prior roles include Interim Joint Working Projects Lead at Boehringer Ingelheim, where oversight of Joint Working initiatives with the NHS was a key responsibility, and Interim International Brand Manager for Pfizer, contributing to the $680m Haemophilia treatment franchise strategy. Alison has also provided freelance project management services at East Surrey Clinical Commissioning Group, focusing on strategic transformation and project delivery. Earlier career achievements at Pfizer involved multiple brand management roles, including European Brand Manager and UK's Senior Vaccines Brand Manager. Alison holds a degree in Business and Finance with a focus on Marketing from the University of Brighton, along with credentials from the Association of the British Pharmaceutical Industry.
This person is not in any teams
This person is not in any offices
Outlook Therapeutics
Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop ONS-5010 / LYTENAVA™ (bevacizumab-vikg) as the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, including wet AMD, DME and BRVO.